UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056294
Receipt number R000055727
Scientific Title How intraoperative Electroencephalogram changes with different sedatives used during general anesthesia.
Date of disclosure of the study information 2024/11/28
Last modified on 2025/09/17 13:45:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

How intraoperative Electroencephalogram changes with different sedatives used during general anesthesia.

Acronym

Effects of sedative drugs on the EEG.

Scientific Title

How intraoperative Electroencephalogram changes with different sedatives used during general anesthesia.

Scientific Title:Acronym

Effects of sedative drugs on the EEG.

Region

Japan


Condition

Condition

general anesthesia

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to record and analyze the electroencephalogram (EEG) during general anesthesia for propofol and sevoflurane, sedative drugs widely used during general anesthesia, and to compare their components.

Basic objectives2

Others

Basic objectives -Others

Postoperative delirium is one of the common complications in postoperative patients, which not only decreases QOL and ADL but also worsens mortality, but there is currently no effective prevention or treatment. The mechanisms of EEG during general anesthesia are still largely unknown, and further development is expected in this field. The purpose of this study is to clarify the characteristics of the electroencephalogram (EEG) of propofol and sevoflurane, sedative drugs widely used during general anesthesia, by recording and analyzing the EEG during general anesthesia and comparing its components. Our future goal is to estimate the effects of sedative drugs on postoperative brain function and to find an anesthesia method that is less prone to delirium.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Differences in Alpha wave power in intraoperative EEG with propofol and sevoflurane

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Anesthesia will be started with sevoflurane, and the sedation method will be switched to propofol intraoperatively. An EEG will be recorded for 20 minutes during each sedation. EEG recordings after the switch will be performed after a 30-minute interval after the sevoflurane expiratory concentration reaches 0%.

Interventions/Control_2

Anesthesia is initiated with propofol, and the sedation method is switched to sevoflurane intraoperatively. An EEG will be recorded for 20 minutes during each sedation. EEG recordings after the switch will be performed after the effective effect site concentration of propofol is less than 0.2 microgram/ml.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who are at least 18 years of age and scheduled to undergo scheduled surgery, with a scheduled surgery time of at least 5 hours.

Key exclusion criteria

Patients with an American Society of Anesthesiologists physical status (ASA-PS) score of 3 or higher
Emergency surgery
Patients with preoperative cognitive dysfunction Patients taking antipsychotic medications
Patients with drug or alcohol dependence
Patients with a history of cerebral infarction, cerebral hemorrhage, or neurosurgery
Patients who cannot have an EEG monitor placed on the forehead due to trauma or skin disorders

Target sample size

40


Research contact person

Name of lead principal investigator

1st name hideki
Middle name
Last name iwata

Organization

kochi medical school

Division name

department of anesthesiology and intensive care medicine

Zip code

783-8505

Address

185-1 Okocho kohasu, Nankoku City, Kochi Prefecture, Japan

TEL

088-880-2471

Email

iwata_hideki@kochi-u.ac.jp


Public contact

Name of contact person

1st name hideki
Middle name
Last name iwata

Organization

kochi medical school

Division name

department of anesthesiology and intensive care medicine

Zip code

783-8505

Address

185-1 Okocho kohasu, Nankoku City, Kochi Prefecture, Japan

TEL

088-880-2471

Homepage URL


Email

iwata_hideki@kochi-u.ac.jp


Sponsor or person

Institute

Kochi university

Institute

Department

Personal name



Funding Source

Organization

kochi medical school

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

kochi medical school

Address

185-1 Okocho kohasu, Nankoku City, Kochi Prefecture, Japan

Tel

088-880-2180

Email

rinri21@kochi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 11 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 06 Month 30 Day

Date of IRB

2023 Year 07 Month 31 Day

Anticipated trial start date

2023 Year 08 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 11 Month 28 Day

Last modified on

2025 Year 09 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055727